Licence agreement with Orient EuroPharma for the commercial launch of Fortacin™ in select territories in Asia, ex The People’s Republic of China
Licence agreement with Wanbang Pharmaceutical Marketing and Distribution Co., Ltd. for the commercial launch of Fortacin™ in The People’s Republic of China
Notice of Board Meeting for unaudited interim results for the six months ended 30 June 2018
Notice of Board Meeting for audited final results for the year ended 31 December 2017